about
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapyBile acid secretion during rat liver carcinogenesisTransient changes in the expression pattern of key enzymes for bile acid synthesis during rat liver regenerationACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemiaEffect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum.Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in MiceSIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.Strategies for overcoming chemotherapy resistance in enterohepatic tumours.ABCC2 is involved in the hepatocyte perinuclear barrier for small organic compounds.Role of amidation in bile acid effect on DNA synthesis by regenerating mouse liver.Bile Acids in Physiology, Pathology and Pharmacology.Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis.Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2.FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver.Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta.Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta.Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.Inhibitory action of cyclobutyrol on the secretion of biliary cholesterol and phospholipids.Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.Protective role of biliverdin against bile acid-induced oxidative stress in liver cells.Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration.Chronic renal failure-induced changes in serum and urine bile acid profiles.Physiological characteristics of allo-cholic acid.Effect of maternal obstructive cholestasis during pregnancy on the biliary transport of horseradish peroxidase in the rat offspring.Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice.Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives.Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity.Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C.Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis.Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes.Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
P50
Q26830005-90F3E1E1-2CFB-4370-9F23-45AEC166DF14Q28374467-7841CA22-028C-4EC0-AB22-B3843B675D7CQ28578227-81C82BCB-7073-4EBB-8C62-32EA2E06138EQ28910477-8AC3EBA0-415A-4685-BAA9-84943ABCA2E2Q35023748-A1323CBD-B1ED-4D3F-B94C-4AB4A8D1E601Q36075389-D63F04C1-1429-451C-A679-FA3DC74481A2Q36908093-67C36E96-F531-443F-A9CC-4DA793D0E8DAQ37231732-38045939-4444-4336-8C34-22F4794579A3Q37722381-A44462BE-D122-44F0-BD54-C7ADEC9257B6Q37764368-BE7221B1-4694-4C7A-AE97-1384EB986490Q38321041-B9119B2D-9B36-432F-8EC9-716239E121ACQ38574493-FCDFF0AF-587A-4DA3-941F-A0901880102BQ38622957-56476A5B-C621-4405-9875-10C600E815A9Q38843336-B12A299E-1966-4CC5-B4D4-7A9989C83BCEQ38950705-0FC7CBF0-32E1-460C-B58C-8E444C63F228Q39147391-052D63A2-A6EA-4D36-8DFA-E2E8498DFEF5Q39211791-8B3342AF-8B49-4F20-962E-38E798F4CBC3Q39440840-D429C765-3404-47E6-89F2-0E798DCC3547Q39447279-DA7F5A62-03BC-4E75-8B0E-857A538B8435Q40277740-A25F510D-4C06-4C9E-89D8-C372D452B3E6Q40403860-77723173-8D8C-4572-B4DA-8E496148237DQ42041250-D20C8E0E-E789-4DC7-84CD-CCB467AF83EBQ42444547-13282850-9D51-493F-B8D6-A042E901E720Q42468393-CE46DF23-71CD-4A92-A75D-F3F3EC161AFBQ42495848-08FFD43D-9266-42E8-8295-85CE4E25F648Q43954102-EF53DB5F-C2EE-45B8-A5CD-3091142301EDQ44229547-CB06A506-9483-4B43-9381-D63D10B9AD67Q44272171-0852B997-A19E-4A46-A195-0498F99B2BEAQ44455852-EAAF66D7-4E63-4B52-8A0A-652E41A4BC91Q45166192-4A46BDFF-7C44-4CDB-BB74-A58AB12C808EQ45871828-13CFC2BC-E813-4A93-A726-399081C3993BQ45884139-122370BD-A2D7-4478-9C7A-72E6C7514584Q45999491-FCB97A2B-6F22-4520-B868-AD330ABDEB3BQ46028611-61D53CAB-0096-42D5-AE09-9FEDCB3AC321Q46442556-7A87357D-1CD8-40CC-ADFE-E76C15E9BC90Q46457191-B08C97DF-EFE7-468A-9D60-48FB8A29984BQ46560168-2806DA25-8616-4F0A-A2D9-37D2BC82F650Q46604324-7121E465-5C59-47E1-B6A4-C900EF14B64BQ46696584-05E8030D-1E0A-4CD0-9DF1-57D479219925Q46928505-55BAFF66-653E-4C1E-8C48-CABE112E00FF
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria J. Monte
@ast
Maria J. Monte
@en
Maria J. Monte
@es
Maria J. Monte
@nl
Maria J. Monte
@sl
type
label
Maria J. Monte
@ast
Maria J. Monte
@en
Maria J. Monte
@es
Maria J. Monte
@nl
Maria J. Monte
@sl
prefLabel
Maria J. Monte
@ast
Maria J. Monte
@en
Maria J. Monte
@es
Maria J. Monte
@nl
Maria J. Monte
@sl
P1053
A-9529-2017
P106
P1153
7006098915
P21
P31
P3829
P496
0000-0003-1844-7428